FULGENT GENETICS, INC. Interest Expense
FULGENT GENETICS, INC. (FLGT) reported Interest Expense of $0 for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-03.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2023-11-03
- FULGENT GENETICS, INC. interest expense for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- FULGENT GENETICS, INC. interest expense for the quarter ending 2023-06-30 was $136.00K, a 172.00% increase year-over-year.
- FULGENT GENETICS, INC. interest expense for the quarter ending 2023-03-31 was $200.00K, a 589.66% increase year-over-year.
- FULGENT GENETICS, INC. interest expense for the quarter ending 2022-12-31 was $161.00K, a 455.17% increase year-over-year.
- FULGENT GENETICS, INC. interest expense for fiscal 2022 was $346.00K, a 195.73% increase from fiscal 2021.
- FULGENT GENETICS, INC. interest expense for fiscal 2021 was $117.00K, a 485.00% increase from fiscal 2020.
- FULGENT GENETICS, INC. interest expense for fiscal 2020 was $20.00K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2023-09-30 | $0.00 10-Q · filed 2023-11-03 | $136.00K derived: sum of 2 quarters · filed 2023-11-03 | $336.00K 10-Q · filed 2023-11-03 | $497.00K derived: sum of 4 quarters · filed 2023-11-03 |
| 2023-06-30 | $136.00K 10-Q · filed 2023-08-04 | $336.00K 10-Q · filed 2023-08-04 | $497.00K derived: sum of 3 quarters · filed 2023-08-04 | $602.00K derived: sum of 4 quarters · filed 2023-11-03 |
| 2023-03-31 | $200.00K 10-Q · filed 2023-05-05 | $361.00K derived: sum of 2 quarters · filed 2023-05-05 | $466.00K derived: sum of 3 quarters · filed 2023-11-03 | $516.00K derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-12-31 | $161.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $266.00K derived: sum of 2 quarters · filed 2023-11-03 | $316.00K derived: sum of 3 quarters · filed 2023-11-03 | $346.00K 10-K · filed 2023-02-28 |
| 2022-09-30 | $105.00K 10-Q · filed 2023-11-03 | $155.00K derived: sum of 2 quarters · filed 2023-11-03 | $185.00K 10-Q · filed 2023-11-03 | $213.00K derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $50.00K 10-Q · filed 2023-08-04 | $79.00K 10-Q · filed 2023-08-04 | $108.00K derived: sum of 3 quarters · filed 2023-08-04 | $138.00K derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $29.00K 10-Q · filed 2023-05-05 | $58.00K derived: sum of 2 quarters · filed 2023-05-05 | $88.00K derived: sum of 3 quarters · filed 2023-05-05 | $117.00K derived: sum of 4 quarters · filed 2023-05-05 |
| 2021-12-31 | $29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $59.00K derived: sum of 2 quarters · filed 2023-02-28 | $88.00K derived: sum of 3 quarters · filed 2023-02-28 | $117.00K 10-K · filed 2023-02-28 |
| 2021-09-30 | $30.00K 10-Q · filed 2022-11-07 | $59.00K derived: sum of 2 quarters · filed 2022-11-07 | $88.00K 10-Q · filed 2022-11-07 | $108.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $29.00K 10-Q · filed 2022-08-04 | $58.00K 10-Q · filed 2022-08-04 | $78.00K derived: sum of 3 quarters · filed 2023-02-28 | $78.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $29.00K 10-Q · filed 2022-05-05 | $49.00K derived: sum of 2 quarters · filed 2023-02-28 | $49.00K derived: sum of 3 quarters · filed 2023-02-28 | $49.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $20.00K derived: sum of 2 quarters · filed 2023-02-28 | $20.00K derived: sum of 3 quarters · filed 2023-02-28 | $20.00K 10-K · filed 2023-02-28 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-09 | $0.00 derived: sum of 2 quarters · filed 2021-11-09 | $0.00 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-10 | $0.00 10-Q · filed 2021-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |